Cutting edge Cloud based technologies focused on human cognition and behavior with a special emphasis on Attentional disorders
I make my dreams a reality, fulfilling myself by continuous learning and exploration in order to become best at what I do. I act without ego, a positive thinker advocating solutions and actions. I am passionate about my work, my ability to contribute to society by improving patient’s lives. I am accountable for my actions and know that my coworkers will support me in my time of need, as I will support them. I am result orientated and loved to exceed expectations, I am MOXONESS.
The MOXOedu brings the clinically proven MOXO engine to the learning domain. Aimed for all students and learners, its short 20-min cloud based assessment creates an attentional profile of the individual student, the entire class or other grouping. Moreover, MOXOedu provides concrete evidence to support the educational team’s professional approach; to better understand student needs and facilitate parent-teacher communication about their child’s learning habits and attentional challenges.
For educators seeking to develop and deploy Social-Emotional Learning programs, MOXOedu™ assesses each learner’s cognitive attentional profile, to provide invaluable data for adaptive personal learning and cognitive development. Thus improving learners’ everyday functioning, well-being, academic abilities and achievements.
Dr. Dayan is an EdTech visionary, ecosystem builder, and a recognized expert in education innovation and entrepreneurship. Dr. Dayan founded EdTech Israel in 2014 with the vision to transform startup-nation to EdTech-nation.
EdTech Israel is a nationwide, unbiased, independent social impact business that successfully connects the Israeli ecosystem with international markets.
Dr. Dayan is also the CEO of Neurotech Solutions . With expertise in attentional profiling and analytics, Neurotech Solutions is a new leader in the field of attention. For the education and learning sectors, Neurotech is the industry’s first cloud-based assessment available for the attention profiling of students and learners.
Dr. Dayan holds a BSc in Electronics Engineering from the well-renowned Technion in Haifa (1982), and a PhD in Education from the University of Haifa (2014).
Prof. César Soutullo is Professor of Psychiatry and Director of ADHD Outpatient Program at The University of Texas Health Science Center in Houston, Texas, USA, McGovern Medical School, at the Louis A. Faillace MD Department of Psychiatry and Behavioral Sciences.
He moved there in 2019, after working 20 years as Director of the Child & Adolescent Psychiatry (CAP) Unit, and Training Director of the CAP Fellowship program at the University of Navarra Clinic, in Pamplona, Spain.
Prof. Soutullo graduated from the Complutense University of Madrid College of Medicine, Spain. After two years of general training (Intern al Medicine, Surgery & Emergency Medicine) in the U.K., he completed his Residency in Psychiatry, and Fellowships in Biological Psychiatry and Child & Adolescent Psychiatry at the University of Cincinnati, Ohio, USA., where he then was Assistant Professor in Clinical Psychiatry.
He completed his PhD at the University of Navarra (2002), in Psychiatry & Neurosciences and his dissertation on Phenomenology of Children at High Risk for Bipolar Disorder obtained the “Extraordinary Thesis Award”.
He received awards such as the AACAP Presidential Scholar Award, the Association for Academic Psychiatry Bristol-Myers Fellowship in Academic Psychiatry, and the Society of Biological Psychiatry Eli Lilly Fellowship Award, and has been Mentor twice in the Donald J. Cohen Fellowship.
His main research interests are ADHD, pediatric mood disorders (especially bipolar), and pediatric psychopharmacology, with research funding from national and international private and public sources. He is member of EUNETHYDIS´ Guidelines Group and of the Scientific Program Committee of the World Federation of ADHD.
Prof. Soutullo is a reviewer of 29 international journals, and is author of 98 original reports, 108 book chapters, 241 abstracts at national or international conferences and has authored or edited 22 books (H Factor: 28), and has been invited to give hundreds of talks at National and international conferences/meetings/courses.
Sam Goldstein, PhD is an Adjunct Assistant Professor at the University of Utah School of Medicine. He currently serves as Editor-in-Chief of the Journal of Attention Disorders and sits on the editorial boards of 6 peer reviewed journals.
Dr. Goldstein has authored over 50 trade and science texts as well as over 36 science-based book chapters and 30 peer reviewed research articles. He has also co-authored ten psychological tests.
He is the Clinical Director of the Neurology Learning and Behavior Center. The center conducts evaluations, consultation and provides treatment services to 300 individuals and families each year.
He is co-editor of the Encyclopedia of Child Development. Recent books include the Handbook of Intelligence: Evolutionary Theory, Historical Perspective and Current Concepts, Handbook of Resilience – 2nd Edition, Raising Resilient Children with Autism Spectrum Disorders, Handbooks of Neurodevelopmental and Genetic Disorders in Children and Adults, Assessment of Intelligence and Achievement, Assessment of Autism Spectrum Disorders, Handbook of Executive Functioning, Assessment of Impairment and Managing Children’s Classroom Behavior: Creating Sustainable Resilient Classrooms. He is the co-author of the Autism Spectrum Rating Scales, Comprehensive Executive Functioning Inventory, Rating Scales of Impairment and the Cognitive Assessment System Second Edition.
He has lectured to thousands of professionals and the lay public in the U.S., South America, Asia, Australia and Europe.
HR, Administration Manager
I am the office manager at Neurotech Solutions, and have many years of experience at employee management, procurement, accounting and sales. I support all training and sales process in Israel and abroad for MOXO, and help administer tests.
I Love my work. The MOXO team and the MOXO test.
2021 Ⓒ Neurotech Solutions Ltd.
Ver: 201609 | ISO 13485:2016 certified
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 877041